Centauri Therapeutics - About the company
Centauri Therapeutics is a series A company based in Kent (United Kingdom), founded in 2014. It operates as a Developer of immunotherapeutics to treat infectious diseases. Centauri Therapeutics has raised $73M in funding from investors like Boehringer Ingelheim Venture Fund, Evotec and REPAIR Impact Fund, with a current valuation of £*****. The company has 3331 active competitors, including 1140 funded and 791 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, Moderna and Sana Biotechnology.
Company Details
Developer of immunotherapeutics to treat infectious diseases. The company has proprietary Alphamer technology based on "programmable immunity" in which chemically synthesised molecules redirect naturally occurring antibodies to selected pathogens to fight the infections.
- Email ID
- *****@centauritherapeutics.com
Key Metrics
Founded Year
2014
Location
Kent, United Kingdom
Stage
Series A
Total Funding
$73M in 12 rounds
Latest Funding Round
Post Money Valuation
£***** as on Jul 10, 2023
Investors
Ranked
288th among 3331 active competitors
Employee Count
24 as on Feb 28, 2026
Investment & Acquisitions
Similar Companies
Legal entities associated with Centauri Therapeutics
Centauri Therapeutics is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Centauri Therapeutics Limited CIN: 08879741 , United Kingdom, Active | Feb 05, 2014 | - | 6 (As on Dec 31, 2022) |
Sign up to download Centauri Therapeutics' company profile
Centauri Therapeutics's funding and investors
Centauri Therapeutics has raised a total funding of $73M over 12 rounds. Its first funding round was on Jul 30, 2015. Its latest funding round was a Series A round on Feb 24, 2026 for $*****. 1 investor participated in its latest round. Centauri Therapeutics has 18 institutional investors and 16 angel investors.
Here is the list of recent funding rounds of Centauri Therapeutics:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Feb 24, 2026 | 7756088 | Series A | 6765257 | 1169493 | 4326347 | 3101836 |
Jul 29, 2025 | 9967095 | Grant (prize money) | 8145157 | 6577582 | 9463353 | |
Nov 26, 2024 | 4090536 | Grant (prize money) | 4179312 | 6236422 | 5524356 |
Access funding benchmarks and valuations. Sign up today!View details of Centauri Therapeutics's funding rounds and investors
Centauri Therapeutics' founders and board of directors
Founder? Claim ProfileHere are the details of Centauri Therapeutics' key team members:
- Jennifer Schneider: CEO of Centauri Therapeutics. They serve on the board of 1 company.Contact Info: 1 email address
Centauri Therapeutics' Board of Directors
Centauri Therapeutics's board has 8 active members. Jennifer Schneider and Stuart Lawson Aca are part of team and Kara Carter, Camilla Petrycer Hansen, Jonathan Stuart Synett, Karen Lackey, Johannes Zanzinger and David Roblin are independent board members.Here is the list of Centauri Therapeutics' board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
hvaghmf | Team | - | Current | 9y 2m |
nenmusl | Team | - | Current | 9y 8m |
Independent board member | - | Current | 2y 8m | |
oduz{fg | Independent board member | - | Current | 6y 5m |
uinywop | Independent board member | - | Current | 2y 6m |
ut{dgay | Independent board member | - | Current | 2y 4m |
foqzpbv | Independent board member | - | Current | 3y 9m |
e{ejcg{ | Independent board member | - | Current | 2y 7m |
sqrquxl | Independent board member | - | Past | 7y 6m |
krivvln | Independent board member | - | Past | 7y 8m |
stgdext | Independent board member | - | Past | 7y 9m |
tamrdjt | Independent board member | - | Past | 3y 5m |
View details of Centauri Therapeutics's Founder profiles and Board Members
Centauri Therapeutics' employee count trend
Centauri Therapeutics has 24 employees as of Feb 26. Here is Centauri Therapeutics's employee count trend over the years:
Uncover Centauri Therapeutics' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Centauri Therapeutics's Competitors and alternates
Top competitors of Centauri Therapeutics include Jazz Pharmaceuticals, Moderna and Sana Biotechnology. Here is the list of Top 10 competitors of Centauri Therapeutics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Jazz Pharmaceuticals 2003, Dublin (Ireland), Public | Developer of novel biopharmaceutical medicines for unmet medical needs | $265M | 82/100 | |
2nd |  Moderna 2010, Cambridge (United States), Public | Developer of mRNA-based therapeutics for a wide range of diseases | $2.78B | 80/100 | |
3rd |  Sana Biotechnology 2018, Seattle (United States), Public | Developer of genetically engineered cell therapies for multiple disorders | $821M | 75/100 | |
4th | C4 Therapeutics 2016, Cambridge (United States), Public | Developer of small molecule drugs for treating cancer | $223M | 74/100 | |
5th | Juno Therapeutics 2013, Seattle (United States), Acquired | Global biopharmaceutical company discovering, developing, and delivering innovative medicines | $317M | 74/100 | |
6th | Blueprint Medicines 2008, Cambridge (United States), Acquired | Developer of selective kinase inhibitors for patients with genomically defined cancers | $115M | 73/100 | |
7th | _1548135965397.png?devicePixelRatio=2&height=30&width=30){kind=logo} Kronos Bio 2017, San Mateo (United States), Acquired | Developer of small molecule based therapeutics for cancer treatment | $271M | 72/100 | |
8th |  Regeneron Pharmaceuticals 1988, Tarrytown (United States), Public | Developer of antibodies for the treatment of cancer, eye diseases, inflammatory diseases & others | - | 72/100 | |
9th |  BeiGene 2010, Cambridge (United States), Public | Developer of targeted and immune-oncology drugs against cancer | $172M | 72/100 | |
10th | MacroGenics 2000, Rockville (United States), Public | Developer of novel biologics for the treatment of autoimmune disorders, cancer and infectious disease | $126M | 72/100 | |
288th | Centauri Therapeutics 2014, Kent (United Kingdom), Series A | Developer of immunotherapeutics to treat infectious diseases | $73M | 58/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Centauri Therapeutics's competitors? Click here to see the top ones
Centauri Therapeutics's Investments and acquisitions
Centauri Therapeutics has acquired Altermune. Centauri Therapeutics has not made any investments as of now.Reports related to Centauri Therapeutics
Here is the latest report on Centauri Therapeutics's sector:
News related to Centauri Therapeutics
Filter this listMedia has covered Centauri Therapeutics for a total of 3 events in the last 1 year.
•
•
£6m support takes Cheshire bio company’s Series A round to £30mTheBusinessDesk.com•Feb 24, 2026•Centauri Therapeutics, AMR Action Fund, Centauri Health Solutions
•
Cheshire med-tech company receives further $5m support from US backerTheBusinessDesk.com•Jul 29, 2025•CARB-X, Centauri Therapeutics
•
•
Centauri Therapeutics Awarded PACE Grant to Advance Anti-infectivesContract Pharma•Nov 26, 2024•Centauri Therapeutics
•
•
Centauri Therapeutics Strengthens Senior Leadership Team With Three Key AppointmentsBusiness Wire•Jul 12, 2022•Centauri Therapeutics
•
Centauri Therapeutics’ $32 Million Series A InvestmentGlobal Legal Chronicle•Feb 19, 2022•Centauri Therapeutics, Boehringer Ingelheim Venture Fund, Evotec, REPAIR Impact Fund and 2 others
•
•
Centauri Therapeutics Ltd - Latest NewsCentauri Therapeutics•Nov 18, 2017•Centauri Therapeutics, Kent County Council, EJ Capital, Wren Capital and 3 others
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Centauri Therapeutics
Explore our recently published companies
- Dl-Dental-2000 - Germany based, Unfunded company
- Kardiokl - Germany based, Unfunded company
- Blk-Care - Unfunded company
- DRPU Software - Ghaziabad based, 2008 founded, Public company
- Independent School District 625 - United States based, Funding Raised company
- Scioto Valley Solar One - Columbus based, 2021 founded, Funding Raised company
